Classification of accelerated phase chronic myeloid leukemia in the era of the BCR::ABL1 tyrosine kinase inhibitors: A work in progress

Am J Hematol. 2023 Sep;98(9):1350-1353. doi: 10.1002/ajh.27007. Epub 2023 Jun 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Drug Resistance, Neoplasm
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Leukemia, Myeloid, Accelerated Phase
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Tyrosine Kinase Inhibitors*

Substances

  • Tyrosine Kinase Inhibitors
  • Antineoplastic Agents
  • Fusion Proteins, bcr-abl
  • Protein Kinase Inhibitors